Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models